Status:
UNKNOWN
CLARITY Imaging Study
Lead Sponsor:
Imperial College London
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
OCT image quality is necessary to provide accurate diagnostic information to ophthalmologists. The increasing resolution of imaging techniques will require ever more high standards of optical transmis...
Eligibility Criteria
Inclusion
- Patients subjectively deemed to have poor image quality by the photographer
Exclusion
- Patients with a known adverse reaction to any of the constituents of the XLHA
- Patients wearing contact lenses
- Patients who have used eyedrops in the past 2 hours
Key Trial Info
Start Date :
April 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03758859
Start Date
April 12 2019
End Date
October 31 2019
Last Update
September 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Western Eye Hospital
London, United Kingdom, NW1 5QH